The Experts below are selected from a list of 687 Experts worldwide ranked by ideXlab platform

Ichiro Katayama - One of the best experts on this subject based on the ideXlab platform.

  • Immunohistochemical Analysis of Interleukin-17 Producing T Helper Cells and Regulatory T Cells Infiltration in Annular Erythema Associated with Sjögren's Syndrome
    Annals of dermatology, 2014
    Co-Authors: Saori Itoi, Atsushi Tanemura, Mamori Tani, Shun Kitaba, Mika Terao, Hiroyuki Murota, Naoki Oiso, Ichiro Katayama
    Abstract:

    Background Peculiar Erythema known as Annular Erythema associated with Sjogren's syndrome (AESS) can be differentiated from autoimmune Annular Erythema and subacute cutaneous lupus Erythematosus, both clinically and histologically. However, there are no detailed investigations on immune competent cells infiltration.

  • Systemic allergic contact dermatitis to palladium inlay manifesting as Annular Erythema
    European journal of dermatology : EJD, 2012
    Co-Authors: Takaaki Hanafusa, Saori Itoi, Mamori Tani, Eriko Yoshioka, Hiroaki Azukizawa, Masahiro Kira, Ichiro Katayama
    Abstract:

    ejd.2012.1794 Auteur(s) : Takaaki Hanafusaa, Eriko Yoshiokaa, Hiroaki Azukizawa azukizaw@derma.med.osaka-u.ac.jp, Saori Itoi, Mamori Tani, Masahiro Kira, Ichiro Katayama Department of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita city, Osaka, 565-0871, Japan a These authors contributed equally to this work as first authors. Annular Erythema occasionally develops in patients with Sjogren syndrome [1, 2]. Here, we report the first case of metal-induced Annular [...]

  • Annular Erythema associated with Sjögren’s syndrome: review of the literature on the management and clinical analysis of skin lesions
    Modern Rheumatology, 2010
    Co-Authors: Ichiro Katayama, Yorihisa Kotobuki, Eiji Kiyohara, Hiroyuki Murota
    Abstract:

    Annular Erythema has been recognized to be a specific, cutaneous manifestation associated with Sjögren’s syndrome. Based on a search of the literature up to 2007, Annular Erythema with Sjögren’s syndrome (AESS) preferentially occurs in Asian but not in Western populations. However, the precise clinical course and standard regimen for the management of AESS have remained obscure, primarily because of its rare occurrence in Western populations and the fact that most Asian cases are isolated reports. In this study, 28 cases of AESS from our department and 92 cases distilled from the literature were enrolled in a retrospective study to evaluate the clinical characteristics and most desirable management of this skin manifestation in Sjögren’s syndrome. We found that 75% of all cases with AESS were positive for both anti-SSA and anti-SSB antibodies. Multiple therapeutic options are available to treat AESS, including oral steroids. Several anti-malaria drugs or tacrolimus ointment have also been reported to be effective against AESS. AESS is a distinct clinical entity, and a small dose of prednisolone (approx. 10 mg) is sufficient to control diseases activity, except in some cases with systemic manifestations, and this treatment has a more rapid clinical effect than topical steroids.

  • Annular Erythema associated with Sjögren's syndrome: review of the literature on the management and clinical analysis of skin lesions.
    Modern rheumatology, 2010
    Co-Authors: Ichiro Katayama, Yorihisa Kotobuki, Eiji Kiyohara, Hiroyuki Murota
    Abstract:

    Annular Erythema has been recognized to be a specific, cutaneous manifestation associated with Sjogren’s syndrome. Based on a search of the literature up to 2007, Annular Erythema with Sjogren’s syndrome (AESS) preferentially occurs in Asian but not in Western populations. However, the precise clinical course and standard regimen for the management of AESS have remained obscure, primarily because of its rare occurrence in Western populations and the fact that most Asian cases are isolated reports. In this study, 28 cases of AESS from our department and 92 cases distilled from the literature were enrolled in a retrospective study to evaluate the clinical characteristics and most desirable management of this skin manifestation in Sjogren’s syndrome. We found that 75% of all cases with AESS were positive for both anti-SSA and anti-SSB antibodies. Multiple therapeutic options are available to treat AESS, including oral steroids. Several anti-malaria drugs or tacrolimus ointment have also been reported to be effective against AESS. AESS is a distinct clinical entity, and a small dose of prednisolone (approx. 10 mg) is sufficient to control diseases activity, except in some cases with systemic manifestations, and this treatment has a more rapid clinical effect than topical steroids.

  • Unusual Annular Erythema associated with myelodysplastic syndrome.
    Dermatology (Basel Switzerland), 2001
    Co-Authors: Toshiyuki Yamamoto, Ichiro Katayama, K. Soejima, Hiroo Yokozeki, T. Koyano, Kiyoshi Nishioka
    Abstract:

    We report a case of unusual Annular Erythema associated with myelodysplastic syndrome (MDS). A 58-year-old male with MDS developed Annular Erythema on his back, scaly Erythema on the dorsa of hands, and exsudative Erythema on his eyelids. Histological examination revealed a mononuclear cell infiltrate around vessels and follicles in the mid- to lower dermis. He had no history of treatment with granulocyte-colony-stimulating factor (G-CSF). Serum granulocyte-macrophage-colony-stimulating factor (GM-CSF) level was slightly elevated (5.84 pg/ml, normal

Masashi Akizuki - One of the best experts on this subject based on the ideXlab platform.

  • recurrent Annular Erythema anti ssa ro and anti ssb la antibodies localized on palms and fingers an elderly man
    Lupus, 1994
    Co-Authors: Minoru Satoh, A. K. Ajmani, Hajime Yamagata, Kenji Okubo, Masashi Akizuki
    Abstract:

    A 69-year-old Japanese man with recurrent Annular Erythema localized on palms and flexor surface of fingers with anti-SSA/Ro and anti-SSB/La antibodies, is reported. The present case indicates that even in an elderly man with atypical localization, Annular Erythema with autoimmunity may be considered and serological analysis should be performed. Systematic studies will be required to understand the relationship between 'recurrent Annular Erythema associated with anti-SSB/La antibodies' in Japanese, subacute cutaneous lupus Erythematosus (SCLE) and 'Annular Erythema associated with Sjogren's syndrome'.

  • Recurrent Annular Erythema Anti-SSA/Ro and Anti-SSB/La Antibodies Localized on Palms and Fingers an Elderly Man:
    Lupus, 1994
    Co-Authors: Minoru Satoh, A. K. Ajmani, Hajime Yamagata, Kenji Okubo, Masashi Akizuki
    Abstract:

    A 69-year-old Japanese man with recurrent Annular Erythema localized on palms and flexor surface of fingers with anti-SSA/Ro and anti-SSB/La antibodies, is reported. The present case indicates that even in an elderly man with atypical localization, Annular Erythema with autoimmunity may be considered and serological analysis should be performed. Systematic studies will be required to understand the relationship between 'recurrent Annular Erythema associated with anti-SSB/La antibodies' in Japanese, subacute cutaneous lupus Erythematosus (SCLE) and 'Annular Erythema associated with Sjogren's syndrome'.

  • Recurrent Annular Erythema associated with anti-SS-B/La antibodies: analysis of the disease-specific epitope.
    The British journal of dermatology, 1992
    Co-Authors: Y. Hoshino, Masashi Akizuki, Takashi Hashimoto, Tsuneyo Mimori, Takeji Nishikawa
    Abstract:

    Summary We have found that anti-SS-B/La antibodies are present in a group of patients with a characteristic recurrent Annular Erythema, and immunological abnormalities. The presence of a disease-specific epitope for this entity has been examined by comparing immunological reactivity of anti-SS-B/La antibodies between these patients and patients with classical Sjogren's syndrome who have anti-SS-B/La antibodies hut do not have this characteristic Erythema. In immunoblotting using three different antigen sources, all the sera from both groups exhibited the same reaction patterns. V8 protease mapping showed that the sera could he divided into three groups by the difference in reactivity to two main digested peptide fragments. However, no significant relationship of the reactivity in peptide mapping between the two patient groups was observed. Further studies are necessary to elucidate the role of anti-SS-B/La antibodies in disease pathogenesis in these patients, in particular by more precise peptide mapping using recombinant SS-B/La antigen proteins.

Toshihiro Tanaka - One of the best experts on this subject based on the ideXlab platform.

Takeji Nishikawa - One of the best experts on this subject based on the ideXlab platform.

  • Recurrent Annular Erythema in juvenile chronic myelogenous leukaemia
    The British journal of dermatology, 1998
    Co-Authors: H. Anzai, Arata Kikuchi, Kinoshita A, Takeji Nishikawa
    Abstract:

    Juvenile chronic myelogenous leukaemia (JCML) is a rare haematological malignancy of myelomonocytic lineage that affects patients less than 4 years of age and is known as an entity different from adult-type chronic myelogenous leukaemia. In JCML, skin manifestations are relatively common but most of them have been reported as a non-specific eruption, which histologically may show changes resembling neurofibromatosis or xanthogranuloma. We present a 2-year-old boy with JCML who developed a recurrent Annular Erythema in which leukaemic infiltrates were confirmed histologically, even though his bone marrow examination suggested that be remained in haematological remission.

  • Similar Ro/SS-A Autoantibody Epitope and Titer Responses in Annular Erythema of Sjögren's Syndrome and Subacute Cutaneous Lupus Erythematosus
    Archives of dermatology, 1996
    Co-Authors: Daniel P. Mccauliffe, Elizabeth Faircloth, Lixiang Wang, Takashi Hashimoto, Yoshiko Hoshino, Takeji Nishikawa
    Abstract:

    Background and Design: Studies were conducted to determine whether certain types of Ro autoantibodies are unique to subacute cutaneous lupus Erythematosus and Annular Erythema of Sjogren's syndrome. Ten American subacute cutaneous lupus Erythematosus sera, 11 Japanese Annular Erythema of Sjogren's syndrome sera, and 39 control sera were tested by enzyme-linked immunosorbent assay with recombinant 52- and 60-kd Ro fusion proteins, native 60-kd Ro protein, and native La/ SS-B protein. Results: Japanese Annular Erythema of Sjogren's syndrome sera and American subacute cutaneous lupus Erythematosus sera share several types of anti-52-kd and anti-60-kd Ro autoantibodies. However, these antibodies were found significantly more often and in significantly higher titers in sera from patients with Sjogren's syndrome who did not manifest these skin diseases. Patients with high Ro autoantibody titers were likely to have overt exocrine gland dysfunction. Conclusions: The failure to identify disease-specific Ro autoantibodies in subacute cutaneous lupus Erythematosus and Annular Erythema of Sjogren's syndrome sera suggests that additional factors influence the development of these skin diseases. However, similarities in the Ro autoantibody responses and in the clinical features of subacute cutaneous lupus Erythematosus and Annular Erythema of Sjogren's syndrome suggest that these two skin diseases might arise from a similar pathogenic process. (Arch Dermatol. 1996;132:528-531)

  • Recurrent Annular Erythema associated with anti-SS-B/La antibodies: analysis of the disease-specific epitope.
    The British journal of dermatology, 1992
    Co-Authors: Y. Hoshino, Masashi Akizuki, Takashi Hashimoto, Tsuneyo Mimori, Takeji Nishikawa
    Abstract:

    Summary We have found that anti-SS-B/La antibodies are present in a group of patients with a characteristic recurrent Annular Erythema, and immunological abnormalities. The presence of a disease-specific epitope for this entity has been examined by comparing immunological reactivity of anti-SS-B/La antibodies between these patients and patients with classical Sjogren's syndrome who have anti-SS-B/La antibodies hut do not have this characteristic Erythema. In immunoblotting using three different antigen sources, all the sera from both groups exhibited the same reaction patterns. V8 protease mapping showed that the sera could he divided into three groups by the difference in reactivity to two main digested peptide fragments. However, no significant relationship of the reactivity in peptide mapping between the two patient groups was observed. Further studies are necessary to elucidate the role of anti-SS-B/La antibodies in disease pathogenesis in these patients, in particular by more precise peptide mapping using recombinant SS-B/La antigen proteins.

Sachiko Miyagawa - One of the best experts on this subject based on the ideXlab platform.

  • Anti-Ro/SSA-associated Annular Erythema in childhood
    The British journal of dermatology, 2006
    Co-Authors: Sachiko Miyagawa, Takashi Iida, Takaya Fukumoto, T. Matsunaga, Akira Yoshioka, Toshihiko Shirai
    Abstract:

    We report four children with anti-Ro/SSA positive who presented with an Annular Erythema as a manifestation of Sjogren's syndrome. One patient had an aseptic meningoencephalitis as well as cutaneous lesions. Children with Annular Erythema should be carefully followed for features of Sjogren's syndrome, which is believed to be a rare condition in children.

  • Autoimmune thyroid disease in anti-Ro/SS-A-positive children with Annular Erythema: report of two cases
    The British journal of dermatology, 2004
    Co-Authors: Sachiko Miyagawa, Akira Yoshioka, M. Tanaka, S. Okamoto, T. Ishihara, Mitsuru Nakajima, K. Taira, Hideo Asada
    Abstract:

    Anti-Ro/SS-A-associated recurrent Annular Erythema is a rare disorder, and represents a cutaneous manifestation of primary Sjogren's syndrome (SS). We report two childhood cases complicated with autoimmune thyroid disease, one with Graves' disease and the other with autoimmune thyroiditis. Both children were positive for anti-Ro/SS-A and anti-La/SS-B antibodies. One patient was lacking clinical SS with objective evidence of salivary gland involvement, while the other was diagnosed with primary SS. Our observation suggests that autoimmune thyroid disease in the subset of anti-Ro/SS-A-positive children with Annular Erythema might occur with similar frequency to that in adult primary SS.

  • Anti-Ro/SSA associated recurrent Annular Erythema: autoimmune response to recombinant 60- and 52-kDa Ro/SSA proteins.
    Journal of dermatological science, 1996
    Co-Authors: Sachiko Miyagawa, Takaya Fukumoto, Takahisa Hachiya, Toshihiko Shirai
    Abstract:

    Recurrent Annular Erythema associated with anti-Ro/SSA antibody response has recently been recognized as a distinct clinical entity. Serum samples from 15 anti-Ro/SSA positive patients with recurrent Annular Erythema were tested by enzyme-linked immunosorbent assay (ELISA) for reactivity with full-length recombinant human 60-kDa and 52-kDa Ro/SSA proteins. All the 15 sera were positive for anti-60-kDa Ro/SSA, and 11 sera (73.3%) contained anti-52-kDa Ro/SSA. These results suggest the importance of 60-kDa polypeptide component of the Ro/SSA particle as a potential target in anti-Ro/SSA associated Annular Erythema.

  • HLA antigens in anti-Ro(SS-A)-positive patients with recurrent Annular Erythema
    Journal of the American Academy of Dermatology, 1993
    Co-Authors: Sachiko Miyagawa, Kazuhiro Dohi, Hiroko Shima, Toshihiko Shirai
    Abstract:

    Background: Recurrent Annular Erythema associated with the anti-Ro(SS-A) antibody response has recently been reported in Orientals. The association is assumed to represent a distinct clinical entity. Objective: Our purpose was to extend knowledge on the immunogenetic spectrum of the disease. Methods: Sixteen anti-Ro(SS-A)-positive Japanese patients with recurrent Annular Erythema and Sjogren's syndrome were studied. The standard complement-dependent microcytotoxicity assay was used to type the HLA-A, -B, -C, -DR, and -DQ, as well as the HLA-DRw52 and -DRw53 antigens. Results: All 16 patients were positive for HLA-DRw52 antigens as compared with 52% of control subjects ( p Conclusion: HLA-DRw52 is closely related to Annular Erythema in anti-Ro(SS-A)-positive Japanese patients with Sjogren's syndrome.